SUPERNUS PHARMACEUTICALS, INC. Debt Securities Available For Sale Excluding Accrued Interest Noncurrent
SUPERNUS PHARMACEUTICALS, INC. (SUPN) had Debt Securities Available For Sale Excluding Accrued Interest Noncurrent of $0 as of 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent · last filed 2025-02-25
- 2024-12-31: Debt Securities Available For Sale Excluding Accrued Interest Noncurrent $0.00.
- 2024-09-30: Debt Securities Available For Sale Excluding Accrued Interest Noncurrent $0.00.
- 2024-06-30: Debt Securities Available For Sale Excluding Accrued Interest Noncurrent $0.00.
- 2024-03-31: Debt Securities Available For Sale Excluding Accrued Interest Noncurrent $11.66M.
| Period end | Debt Securities Available For Sale Excluding Accrued Interest Noncurrent |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-25 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-04 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-06 |
| 2024-03-31 | $11.66M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $16.62M 10-K · filed 2025-02-25 |
| 2023-09-30 | $25.13M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $37.48M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $54.16M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $93.90M 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |